Related Links

 

Click here to go directly to the members only pages of the Industrial Pharmacy Section.

The Pharmabridge project aims to strengthen pharmaceutical services and pharmacy education in developing and transitional countries through coordinated support from pharmacy establishments in developed and more advanced developing countries. Click here to read more.

 

Industrial Pharmacy Section

About us  | How we work | IPS Annual Report 2015Activities 

News

IPS members recognised

Former IPS president Linda Hakes was elected as a Vice President of FIP during the FIP Council elections in Buenos Aires in August. Dr Hakes, originally from the UK, is a pharmacist who has worked in drug development for 40 years. “FIP should strongly advocate the retention of science and scientific principles within the pharmacy curriculum while recognising that most graduates will eventually work in practice,” she said in her election statement. The elections were held on the eve of the 76th FIP congress, at which Michael Anisfeld, current IPS President, was awarded with an FIP Fellowship.

 

About us and our objective

Founded in 1955, FIP’s Industrial Pharmacy Section (IPS) has expanded to a worldwide industrial pharmacy network. It embraces all functions where industrial pharmacists are employed.

Members of the section benefit from:

  • International journal Industrial Pharmacy (quarterly)
  • Quarterly IPS Newsletter including early information on pharmaceutical manufacturing science & practice training workshops, up-to-date information on development and manufacturing, biotechnology, QC/QA and the regulation of pharmaceuticals
  • Free participation in IPS webinars (typically valued at USD 150 each)
  • Reduced rates at FIP symposia and training events
  • Global networking opportunities at the annual FIP congress and IPS workshops year-round, providing access to colleagues with technical, quality and regulatory expertise
  • Discussion forums on current industrial topics
  • Student internships

We invite any pharmacists and scientists working in any area of the pharmaceutical industry or with the regulatory authorities to join us. Enhance and strengthen your professional life and contribute to the international community of industrial pharmacists: click here.

How we work

The current Statutes of the Industrial Pharmacy Section were adopted by the FIP Council in 2009.

The executive committee members are as follow:

President Michael Anisfeld (United States)
Vice President Sola Solarin (Nigeria)
Treasurer Erik Naeser (Switzerland)
Secretary Ulf Janzon (Sweden)

Contact us via ips@fip.org

Members of IPS ExCo at FIP 2016 Congress in Buenos Aires (Left to right: Anna Laven (Germany), Ulf Janzon (Sweden), Gabrielle Wiederkehr (Switzerland), Kerstin Neumann (Germany), Michael Anisfeld (IPS President, USA), Ching-Yi Hsu (Taiwan), Sini Eskola (Belgium), Mathew Cherian (USA), Didier Mouliom (France), Igor de Castro (Brazil)

 

The following roles are also undertaken within ExCo: 

Functional roles Responsibility
Regulatory    Gabrielle Wiederkehr (Switzerland)
WHO Guideline Coordinator Michael Anisfeld (United States)
Regulatory Updates (for IPS Newsletter) Michael Anisfeld (United States)
Media & Communications  
Newsletter editor Forum Jalundhwala (India)
Industrial Pharmacy editor Forum Jalundhwala (India)
Social media (FB/Linked-In/Twit) editor Kerstin Neumann (Germany)
Website coordinator/Discussion forum manager Igor de Castro (Brazil)
Education & Outreach  
Awards coordinator Avanthi Govender (South Africa)
Congress coordinator Ulf Janzon (Sweden)
Scientific updates (Congress/Seminars input) Mathew Cherian (USA)
Webinar coordinator Sola Solarin (Nigeria)
IPS development coordinator Anna Laven
Membership management     Didier Mouliom (France)  
Finance  
Marketing/Sales coordinator Anna Laven